Insights - Shares of biopharmaceutical company Zogenix, Inc. (ZGNX) are up 16% in trading on Wednesday after the company announced that a new, abuse-deterrent formulation of Zohydro … Continue Reading
Read nowInsights - Synageva BioPharma (GEVA) announced Monday after the close that the phase 3 ARISE trial of lead drug candidate sebelipase alfa successfully met its primary endpoint, and the company will … Continue Reading
Read nowInsights - Retrophin (RTRX) dropped on Friday before rallying through the day on early results for RE-024. Here's why.
Read nowInsights - Flamel Technologies (FLML) announced on Monday that the FDA has approved VAZCULEP (phenylephrine hydrochloride), the company’s alpha-1 adrenergic receptor agonist for the treatment of hypotension resulting … Continue Reading
Read nowRecap - The announcement came two weeks ahead of schedule, and Afrezza is now approved to improve glycemic control in adults with diabetes mellitus. Afrezza’s label includes a Black Box Warning … Continue Reading
Read nowInsights - Driven by Canada’s lower corporate tax rate, Auxilium Pharmaceuticals (AUXL) plans to merge with QLT Inc. (QLTI), a small Canadian biotechnology company that essentially put … Continue Reading
Read nowInsights - Shares of Vertex Pharmaceuticals (VRTX) are up 50% to $100 following success in two phase 3 studies of a cystic fibrosis drug combination that could be worth north … Continue Reading
Read now
